Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B

Condition:   Hemophilia Intervention:   Drug: Fitusiran Sponsor:   Genzyme, a Sanofi Company Not yet recruiting

Source: ClinicalTrials.gov - June 4, 2019 Category: Research Source Type: clinical trials